JOSÉ LUIS
GONZÁLEZ LARRIBA
Catedrático de universidad
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (2)
2007
-
Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates
EJC SUPPLEMENTS
-
Elevated levels of thioredoxin (Trx) in serum correlate with poor outcome in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (pts)
EJC SUPPLEMENTS